Every SEC Form 3/4/5 on record for this filer (CIK 2090209) — 1 issuer, 9 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| HALO | HALOZYME THERAPEUTICS, INC. | SVP, CHIEF OPERATING OFFICER | 2025-10-06 → 2026-03-10 | 6 | −$2M |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| HALO | 2026-03-10 | Sell | 8,857 | $67.64 | $599,087 | 7,055 |
| HALO | 2026-03-09 | Sell | 17,900 | $67.75 | $1M | 16,466 |
| HALO | 2026-03-09 | Sell | 2,100 | $68.25 | $143,325 | 14,366 |
| HALO | 2025-11-01 | Sell | 4,263 | $65.19 | $277,905 | 12,737 |
1 of 1 issuers are covered and open a security page; the rest are on file here only.